Capreomycin: Difference between revisions

Jump to navigation Jump to search
m (Changed protection level for "Capreomycin" ([Edit=Allow only autoconfirmed users] (expires 14:09, 31 December 2013 (UTC)) [Move=Allow only autoconfirmed users] (expires 14:09, 31 December 2013 (UTC))))
m (Redirected page to Capreomycin sulfate)
 
Line 1: Line 1:
{{drugbox
#REDIRECT [[Capreomycin sulfate]]
| IUPAC_name =
| image = Capreomycin IA.svg
| image2 = Capreomycin IB.svg
| CAS_number = 11003-38-6
| ATC_prefix = J04
| ATC_suffix = AB30
| ATC_supplemental =
| PubChem = 3032400
| DrugBank = APRD00844
| C = 25 | H = 44 | N = 14 | O = 8
| molecular_weight = 668.706 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| pregnancy_category =
| legal_status =
| routes_of_administration =
}}
{{SI}}
 
 
'''Capreomycin''' is a [[peptide]] [[antibiotic]], commonly grouped with the [[aminoglycoside]]s, which is given in combination with other [[antibiotics]] for [[tuberculosis]]. Adverse effects include [[nephrotoxicity]] and 8th cranial [[neurotoxicity|nerve toxicity]].
 
The drug should not be given with [[streptomycin]] or other drugs that may damage the 8th nerve.
 
{{Antimycobacterials}}
 
[[Category:Tuberculosis]]
[[Category:Aminoglycoside antibiotics]]
[[es:capreomicina]]
 
{{WH}}
{{WS}}

Latest revision as of 02:32, 4 January 2014